Oliver von Stein
Vorstandsvorsitzender bei Berlin Cures Holding AG
Profil
Oliver von Stein was the founder and had founded InDex Pharmaceuticals Holding AB in 2000, where he held the title of Chief Scientific Officer from 2009 to 2013.
He is currently the Chief Executive Officer at Berlin Cures Holding AG since 2023.
Dr. von Stein's former positions include Operations Director at Silence Therapeutics Plc from 2014 to 2015 and Project Leader at MediGene AG.
Dr. von Stein holds a doctorate degree from Karlsruher Institut für Technologie.
Aktive Positionen von Oliver von Stein
| Unternehmen | Position | Beginn |
|---|---|---|
Berlin Cures Holding AG
 Berlin Cures Holding AG BiotechnologyHealth Technology Part of Berlin Cures GmbH, Cures Holding AG is a Swiss joint stock company based in Zug, Switzerland. Cures Holding AG specializes in developing a neutralizer for pathogenic functional autoantibodies. The company is home to an unrivaled platform-technology established around BC 007. The company was founded in 2014 by Johannes Müller, and Oliver von Stein has been the CEO of the company since 2023. | Vorstandsvorsitzender | 15.06.2023 |
Ehemalige bekannte Positionen von Oliver von Stein
| Unternehmen | Position | Ende |
|---|---|---|
| SILENCE THERAPEUTICS PLC | Geschäftsführer | 01.08.2015 |
| MEDIGENE AG | Corporate Officer/Principal | - |
| INDEX PHARMACEUTICALS HOLDING AB | Gründer | - |
Ausbildung von Oliver von Stein
| Karlsruher Institut für Technologie | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| INDEX PHARMACEUTICALS HOLDING AB | Health Technology |
| MEDIGENE AG | Health Technology |
| SILENCE THERAPEUTICS PLC | Commercial Services |
| Private Unternehmen | 1 |
|---|---|
Berlin Cures Holding AG
Berlin Cures Holding AG BiotechnologyHealth Technology Part of Berlin Cures GmbH, Cures Holding AG is a Swiss joint stock company based in Zug, Switzerland. Cures Holding AG specializes in developing a neutralizer for pathogenic functional autoantibodies. The company is home to an unrivaled platform-technology established around BC 007. The company was founded in 2014 by Johannes Müller, and Oliver von Stein has been the CEO of the company since 2023. | Health Technology |
